CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Teva Pharmaceutical Industries Limited

TEVA
$18.32B
Large Cap
NYSEPharmaceutical PreparationsPharmaceutical🇺🇸North AmericaTEL AVIV33.9K employees

Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

Website

Drugs in Pipeline

100

Phase 3 Programs

61

Upcoming Catalysts

5

Next Catalyst

May 31, 2026

12w

Market Overview

Stock performance and key metrics

TEVA News
Catalyst Timeline

5 upcoming, 0 past

Drug Pipeline

Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

Phase 3

Asthma

ProAir HFA inhaler

Phase 3

Asthma

Albuterol Sulfate

Phase 3

Asthma

Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol

Phase 3

Rhinitis, Allergic, Perennial

Tapinarof Cream 1%

Phase 3

Plaque Type Psorisis

beclomethasone dipropionate (QVAR)

Phase 3

Asthma

Bendamustine hydrochloride

Phase 3

Non-Hodgkin Lymphoma

rasagiline mesylate

Phase 3

Multiple System Atrophy

GA 20 mg/mL

Phase 3

Relapsing-Remitting Multiple Sclerosis

Albuterol

Phase 3

Asthma

vincristine

Phase 3

Non-Hodgkin's Lymphoma

Hydrocodone ER

Phase 3

Low Back Pain

Imiquimod Cream, 3.75%

Phase 3

Actinic Keratosis

BDP Nasal Aerosol

Phase 3

Allergic Rhinitis

Beclomethasone Dipropionate 640

Phase 3

Persistent Asthma

DR-103

Phase 3

Pregnancy Prevention

Balugrastim

Phase 3

Chemotherapy-induced Neutropenia

albuterol aerosol by HFA MDI

Phase 3

Exercise-induced Bronchospasm

DR-1021

Phase 3

Healthy

Trifarotene 0.005 % Topical Cream

Phase 3

Acne Vulgaris

Prednisone capsules

Phase 3

Perennial Allergic Rhinitis

Beclomethasone dipropionate breath-actuated inhaler

Phase 3

Persistent Asthma

Proventil® HFA

Phase 3

Asthma

Neugranin

Phase 3

Chemotherapy-induced Neutropenia

Fluticasone Propionate

Phase 3

Asthma

TV-46000

Phase 3

Schizophrenia

Albuterol/salbutamol

Phase 3

Asthma

TEV-50717

Phase 3

Cerebral Palsy, Dyskinetic

Reslizumab

Phase 3

Eosinophilic Asthma

Albuterol sulfate (ABS)

Phase 3

Chronic Obstructive Pulmonary Disease

Budesonide/Formoterol SPIROMAX®

Phase 3

Asthma

Glatiramer acetate (GA)

Phase 3

Relapsing Remitting Multiple Sclerosis

lipegfilgrastim

Phase 3

Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Glatiramer Acetate (DB)

Phase 3

Multiple Sclerosis

Fp/ABS

Phase 3

Asthma

Laquinimod

Phase 3

Multiple Sclerosis

TV-46763

Phase 3

Pain

Glatiramer Acetate (GA) 40 mg

Phase 3

Relapsing Remitting Multiple Sclerosis

rasagiline mesylate 1.0 mg

Phase 3

Parkinson's Disease

Patent 2027

BDP

Phase 3

Allergic Rhinitis

DR-102

Phase 3

Contraception

TEV-56248

Phase 3

Asthma

Fremanezumab

Phase 3

Migraine

Beclomethasone dipropionate

Phase 3

Seasonal Allergic Rhinitis

Diclofenac sodium

Phase 3

Actinic Keratosis

Glatiramer Acetate 20 mg/0.5 mL

Phase 3

Multiple Sclerosis

Bendamustine

Phase 3

Leukemia

TV-44749

Phase 3

Schizophrenia

Glatiramer Acetate

Phase 3

Relapsing Remitting Multiple Sclerosis

FS MDPI

Phase 3

Asthma

Albuterol Spiromax®

Phase 3

Asthma

Albuterol Spiromax

Phase 3

Exercise-Induced Bronchoconstriction (EIB)

Fp MDPI

Phase 3

Persistent Asthma

Estradiol

Phase 3

Dyspareunia

Albuterol MDPI

Phase 3

Asthma

1.0 mg rasagiline mesylate

Phase 3

Parkinson's Disease

ACR16

Phase 3

Huntington Disease

Non-Oral Corticosteroid (non-OCS) Asthma Medication

Phase 3

Asthma

Beclomethasone dipropionate BAI

Phase 3

Asthma

BDP HFA

Phase 3

Seasonal Allergic Rhinitis

SD-809

Phase 3

Chorea

ProAir® HFA

Phase 2

Asthma

40 mg glatiramer acetate

Phase 2

Amyotrophic Lateral Sclerosis

Nebulized IVX-0142

Phase 2

Asthma

laquinimod 0.3

Phase 2

Relapsing Remitting Multiple Sclerosis

Tizanidine (sublingual or oral)

Phase 2

Muscle Spasticity

TEV-53408

Phase 2

Celiac Disease

CEP-18770

Phase 2

Multiple Myeloma

TV-1380 150 mg

Phase 2

Cocaine Addiction

desogestrel/ethinyl estradiol and ethinyl estradiol

Phase 2

Hemostasis

Beclomethasone dipropionate HFA Nasal Aerosol

Phase 2

Seasonal Allergic Rhinitis

Mometasone furoate

Phase 2

Seasonal Allergic Rhinitis

tbo-filgrastim

Phase 2

Neutropenia

TEV-56286

Phase 2

Multiple System Atrophy

Tiotropium HFA BAI 4.5 mcg

Phase 2

COPD

Albuterol HFA-BOI

Phase 2

Asthma

TEV-48574 Dose Regimen A

Phase 2

Crohn Disease

etiprednol dicloacetate

Phase 2

Crohn's Disease

Mycophenolate Mofetil

Phase 2

Lupus Nephritis

talampanel

Phase 2

Dyskinesias

Omacetaxine mepesuccinate

Phase 2

Chronic Myeloid Leukemia

91-day Levonorgestrel Oral Contraceptive

Phase 2

Hemostasis

TV-45070

Phase 2

Postherpetic Neuralgia

glatiramer acetate 20 mg

Phase 2

Relapse-Remitting Multiple Sclerosis

ProAir HFA

Phase 2

Asthma

glatiramer acetate 20 mg, with mitoxantrone

Phase 2

Relapsing Remitting Multiple Sclerosis

Glatiramer Acetate, N-Acetylcysteine

Phase 2

Relapse Remitting Multiple Sclerosis

Rasagiline

Phase 2

Dementia

Flovent Diskus

Phase 2

Asthma

LBR-101 High Dose

Phase 2

Chronic Migraine

glatiramer acetate with minocycline

Phase 2

Relapse Remitting Multiple Sclerosis

Advair Diskus

Phase 2

Asthma

TP-38

Phase 2

Recurrent Glioblastoma Multiforme

Bronchodilator

Phase 2

Asthma

LBR-101 Low Dose

Phase 2

Episodic Migraine Headache

TEV-48574

Phase 2

Crohn Disease

Metronidazole

Phase 2

Bacterial Vaginosis

temozolomide(TMZ) 75mg

Phase 2

Glioblastoma Multiforme

TV-1106

Phase 2

Growth Hormone Deficiency

Delayed Release 6MP or Calcitriol vs. Purinethol

Phase 2

Crohn's Disease

Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply